Literature DB >> 23886659

The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE study.

Giacomo Faden1, Giorgio Faganello, Stefania De Feo, Nicola Berlinghieri, Luigi Tarantini, Andrea Di Lenarda, Pompilio Faggiano, Giovanni Cioffi.   

Abstract

AIMS: Type 2 diabetes mellitus (DM) is associated with higher risk of heart failure. Over the last three decades several studies demonstrated the presence of asymptomatic systolic and/or diastolic left ventricular (LV) dysfunction (asymLVD) in patients with normal LV ejection fraction (LVEF). Purpose of our study was to assess the prevalence and factors associated with asymLVD in DM patients by echocardiographic indexes more sensitive than LVEF and transmitral flow detected by pulsed Doppler.
METHODS: 386 DM patients without overt cardiac disease were enrolled from January to October 2011. Stress-corrected midwall shortening (sc-MS) and mitral annular peak systolic velocity (S') were considered as indexes of systolic function of circumferential and longitudinal myocardial fibers, respectively. Early diastolic velocity of transmitral flow was divided by early diastolic Tissue Doppler velocity of mitral annulus for identifying diastolic LVD.
RESULTS: asymLVD was detected in 262 patients (68%). 106 (27%) had isolated systolic asymLVD, 61 (16%) isolated diastolic asymLVD; in 95 (25%) systolic and diastolic asymLVD coexisted. Patients with asymLVD were older, had lower glomerular filtration rate, higher levels of glycated hemoglobin, C reactive protein, LV mass, relative wall thickness and prevalence of valve calcifications. Older age (HR 1.1 [1.02-1.18], p=0.01), aortic valve calcifications (HR 6.3 [1.31-30.31], p=0.02), LV concentric geometry defined as relative wall thickness ≥0.43 (HR 15.44 [2.96-80.44], p=0.001) were independent predictors of asymLVD at multivariate analysis.
CONCLUSIONS: Using suitable echocardiographic indexes, asymLVD is detectable in two/third of DM patients without overt cardiac disease and is predicted by older age, cardiac valve calcifications and LV concentric remodeling.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diastolic function; Longitudinal function; Midwall shortening; Systolic function; Type 2 diabetes

Mesh:

Year:  2013        PMID: 23886659     DOI: 10.1016/j.diabres.2013.07.004

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  24 in total

1.  Prevalence, types and factors associated with echocardiographic abnormalities among newly diagnosed diabetic patients at Mulago Hospital.

Authors:  Martin Muddu; Edrisa Mutebi; Charles Mondo
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

2.  Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis. A prospective tissue Doppler echocardiography study.

Authors:  Giovanni Cioffi; Ombretta Viapiana; Federica Ognibeni; Andrea Dalbeni; Davide Gatti; Silvano Adami; Carmine Mazzone; Giorgio Faganello; Andre Di Lenarda; Maurizio Rossini
Journal:  Herz       Date:  2015-05-20       Impact factor: 1.443

Review 3.  The two faces of miR-29.

Authors:  Anna Ślusarz; Lakshmi Pulakat
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2015-07       Impact factor: 2.160

4.  Association of cardiovascular disease risk factors with left ventricular mass, biventricular function, and the presence of silent myocardial infarction on cardiac MRI in an asymptomatic population.

Authors:  Eliel Nham; Sung Mok Kim; Sang-Chol Lee; Sung-A Chang; Jidong Sung; Soo Jin Cho; Shin Yi Jang; Yeon Hyeon Choe
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-21       Impact factor: 2.357

5.  Left and right atrial phasic function and deformation in untreated patients with prediabetes and type 2 diabetes mellitus.

Authors:  Marijana Tadic; Sanja Ilic; Cesare Cuspidi; Branislava Ivanovic; Ljiljana Bukarica; Nada Kostic; Tamara Marjanovic; Vesna Kocijancic; Vera Celic
Journal:  Int J Cardiovasc Imaging       Date:  2014-09-12       Impact factor: 2.357

Review 6.  Consensus document: management of heart failure in type 2 diabetes mellitus.

Authors:  Upendra Kaul; Saumitra Ray; D Prabhakar; Arun Kochar; Kamal Sharma; Prakash Kumar Hazra; Subhash Chandra; Dharmesh Ramakant Bhai Solanki; Anjan Lal Dutta; Viveka Kumar; M Srinivas Rao; Abraham Oomman; Sameer Dani; Brian Pinto; T R Raghu
Journal:  Heart Fail Rev       Date:  2021-09       Impact factor: 4.214

7.  Nigella sativa: A potential natural protective agent against cardiac dysfunction in patients with type 2 diabetes mellitus.

Authors:  Abdullah Bamosa; Huda Kaatabi; Ahmed Badar; Akram Al-Khadra; Abdulmohsen Al Elq; Bodour Abou-Hozaifa; Fatma Lebda; Sameeh Al-Almaie
Journal:  J Family Community Med       Date:  2015 May-Aug

8.  Regulation of cardiac expression of the diabetic marker microRNA miR-29.

Authors:  Nicholas Arnold; Purushotham Reddy Koppula; Rukhsana Gul; Christian Luck; Lakshmi Pulakat
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

9.  Echocardiographic markers of inducible myocardial ischemia at baseline evaluation preparatory to exercise stress echocardiography.

Authors:  Antonella Cherubini; Giovanni Cioffi; Carmine Mazzone; Giorgio Faganello; Giulia Barbati; Luigi Tarantini; Giulia Russo; Carlo Stefenelli; Franco Humar; Eliana Grande; Maurizio Fisicaro; Claudio Pandullo; Andrea Di Lenarda
Journal:  Cardiovasc Ultrasound       Date:  2016-06-01       Impact factor: 2.062

Review 10.  The Diabetic Cardiomyopathy: The Contributing Pathophysiological Mechanisms.

Authors:  Teresa Salvatore; Pia Clara Pafundi; Raffaele Galiero; Gaetana Albanese; Anna Di Martino; Alfredo Caturano; Erica Vetrano; Luca Rinaldi; Ferdinando Carlo Sasso
Journal:  Front Med (Lausanne)       Date:  2021-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.